

ABCDx focuses on identifying, clinically validating, and bringing to market mobile brain diagnostic technologies powered by cutting-edge blood-based biomarkers, all integrated through its proprietary
Software-as-a-Medical-Device platform
Software-as-a-Medical-Device platform
About the founders

.jpeg)
Prof. Sanchez & Dr. Montaner Villalonga are widely acknowledged as leading experts in brain biomarkers. Their combined knowledge spans biomarker discovery, awareness, and clinical validation.
Their ongoing breakthroughs in identifying new brain biomarkers form the intellectual property foundation of ABCDx and enable accelerated clinical validation for the company’s medical diagnostic devices.
what we do ?
Swiss based company, specialized in the discovery, clinical validation and commercialization of point-of-care disagnostics with advanced blood-based biomarkers for brain injuries
Discover more
Discover more
who we are ?
Swiss based company, specialized in the discovery, clinical validation and commercialization of point-of-care disagnostics with advanced blood-based biomarkers for brain injuries
Discover more
Discover more
news